Anzeige
Meldung des Tages: Gold über 5.000 USD verändert die Wirtschaftlichkeit grundlegend!

Citius Pharmaceuticals Aktie News

Aktie
WKN:  A40MD0 ISIN:  US17322U3068 US-Symbol:  CTXR Branche:  Pharmazeutika Land:  USA
0,82 $
-0,0065 $
-0,79%
0,6898 € 26.01.26
Depot/Watchlist
Marktkapitalisierung *
5,52 Mio. €
Streubesitz
76,16%
KGV
-
Index-Zuordnung
-

Citius Pharmaceuticals News

12.06.25 - PR Newswire
After Major Oncology Conference, All Eyes Turn to Industry Innovation
After Major Oncology Conference, All Eyes Turn to Industry Innovation PR Newswire
12.06.25 - PR Newswire
After Major Oncology Conference, All Eyes Turn to Industry Innovation
After Major Oncology Conference, All Eyes Turn to Industry Innovation PR Newswire
12.06.25 - PR Newswire
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-​The-Market Under Nasdaq Rules PR Newswire
10.06.25 - PR Newswire
Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules
Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-​The-Market Under Nasdaq Rules PR Newswire
09.06.25 - PR Newswire
Citius Oncology Enters into Distribution Services Agreement with Cardinal Health
Citius Oncology Enters into Distribution Services Agreement with Cardinal Health PR Newswire
14.05.25 - PR Newswire
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update PR Newswire
05.05.25 - PR Newswire
Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference PR Newswire
01.04.25 - PR Newswire
Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock
Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock PR Newswire
14.02.25 - PR Newswire
Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update
Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update PR Newswire
06.02.25 - PR Newswire
Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services
Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services PR Newswire

Newssuche

Videos

newspaper
01:40 Uhr +0,18%
Wahnsinn! Warum Daytrader im FDAX oft verlieren
Ab Montag, dem 2. Februar börsentäglich ab 18 Uhr - FEIERABEND-​TRADING! Echte Trades auf Basis ... Mehr »